Matches in Wikidata for { <http://www.wikidata.org/entity/Q92807818> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q92807818 description "artículu científicu espublizáu en setiembre de 2019" @default.
- Q92807818 description "scientific article published on 01 September 2019" @default.
- Q92807818 description "wetenschappelijk artikel" @default.
- Q92807818 description "наукова стаття, опублікована 1 вересня 2019" @default.
- Q92807818 description "գիտական հոդված հրատարակված 2019 թվականի սեպտեմբերի 1-ին" @default.
- Q92807818 name "An initial company experience gained from using preclinical CiPA testing paradigm in a drug discovery setting: Challenges still lying ahead" @default.
- Q92807818 name "An initial company experience gained from using preclinical CiPA testing paradigm in a drug discovery setting: Challenges still lying ahead" @default.
- Q92807818 type Item @default.
- Q92807818 label "An initial company experience gained from using preclinical CiPA testing paradigm in a drug discovery setting: Challenges still lying ahead" @default.
- Q92807818 label "An initial company experience gained from using preclinical CiPA testing paradigm in a drug discovery setting: Challenges still lying ahead" @default.
- Q92807818 prefLabel "An initial company experience gained from using preclinical CiPA testing paradigm in a drug discovery setting: Challenges still lying ahead" @default.
- Q92807818 prefLabel "An initial company experience gained from using preclinical CiPA testing paradigm in a drug discovery setting: Challenges still lying ahead" @default.
- Q92807818 P1433 Q92807818-70FF80DE-3834-4F0E-AC92-6CDF2C724BFD @default.
- Q92807818 P1476 Q92807818-A77358FA-8457-4A53-BEAC-C387AABD9B0C @default.
- Q92807818 P2093 Q92807818-256DA96A-2ACD-449E-AFD1-AADB2F639220 @default.
- Q92807818 P2093 Q92807818-42700764-9FE1-48AC-8D96-0D3C9DE2C749 @default.
- Q92807818 P2093 Q92807818-44B3D038-A7CC-47CB-AE96-267F424FFF1E @default.
- Q92807818 P2093 Q92807818-5284A651-ACFF-4456-AC9A-9137AC2167B2 @default.
- Q92807818 P2093 Q92807818-CBCA09DE-8340-4E12-9AFC-1EB9A00EE26F @default.
- Q92807818 P2093 Q92807818-CF4AB5DB-298E-4AC5-B05C-8E1052247855 @default.
- Q92807818 P2093 Q92807818-D584F3AA-2245-462E-9831-B60F61246063 @default.
- Q92807818 P2093 Q92807818-D74F73F6-83CC-4B9B-AE0B-0A010AA0EC94 @default.
- Q92807818 P304 Q92807818-E6E2099B-C845-4211-B661-3221DA07AD2C @default.
- Q92807818 P31 Q92807818-7521970F-0E20-4FCD-AB10-21DD4C5037BE @default.
- Q92807818 P356 Q92807818-D534B469-0654-44F6-AB24-76A9D298F119 @default.
- Q92807818 P478 Q92807818-3AEBA322-2F20-4A37-98D1-D0CC36BC1277 @default.
- Q92807818 P577 Q92807818-1FED40CA-B401-4B63-A299-7468A1B4590B @default.
- Q92807818 P698 Q92807818-30F570B8-E220-4B11-B896-0D1EC71B1746 @default.
- Q92807818 P921 Q92807818-C9126D44-3C06-43DA-959D-168044A66FDF @default.
- Q92807818 P356 J.VASCN.2019.05.098 @default.
- Q92807818 P698 31963012 @default.
- Q92807818 P1433 Q15724529 @default.
- Q92807818 P1476 "An initial company experience gained from using preclinical CiPA testing paradigm in a drug discovery setting: Challenges still lying ahead" @default.
- Q92807818 P2093 "Alexandra Rjasanow" @default.
- Q92807818 P2093 "Annie Delaunois" @default.
- Q92807818 P2093 "Blanca Rodriguez" @default.
- Q92807818 P2093 "Elisa Passini" @default.
- Q92807818 P2093 "Godfrey Smith" @default.
- Q92807818 P2093 "Jean-Pierre Valentin" @default.
- Q92807818 P2093 "Mark Bryant" @default.
- Q92807818 P2093 "Simon Hebeisen" @default.
- Q92807818 P304 "106595" @default.
- Q92807818 P31 Q13442814 @default.
- Q92807818 P356 "10.1016/J.VASCN.2019.05.098" @default.
- Q92807818 P478 "99" @default.
- Q92807818 P577 "2019-09-01T00:00:00Z" @default.
- Q92807818 P698 "31963012" @default.
- Q92807818 P921 Q1418791 @default.